Phillips 66 Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Phillips 66 on February 26, 2021. The report discloses a significant executive appointment within the Company's leadership structure.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation and appointment details.
Material Changes
The primary material change reported is the appointment of Mark E. Lashier as President and Chief Operating Officer, effective April 1, 2021. Mr. Lashier previously served as President and CEO of Chevron Phillips Chemical Company LLC (CPChem), a joint venture in which Phillips 66 holds a 50% interest.
Compensation and Management Commentary
In connection with his appointment, Mr. Lashier's compensation package includes the following:
- Base Salary: $1,100,000 annually.
- Variable Incentive Cash Program (VCIP): Target opportunity of 110% of base salary, contingent on performance goals.
- Long-Term Incentive Grant (2021): Total value of $6,050,000 (550% of base salary), comprised of 50% performance shares, 25% stock options, and 25% restricted stock units.
- One-Time Grant: Restricted stock units valued at $1,000,000, vesting in two equal installments starting on the first anniversary of the grant date. This grant compensates for forfeited CPChem compensation.
Mr. Lashier is also eligible for standard executive benefit plans, including health insurance, disability income protection, and retirement/severance benefits.
Investor Verification Checklist
- Verify the effective date of the new President and COO appointment (April 1, 2021).
- Confirm the total value of the 2021 long-term incentive grant ($6,050,000) and its composition.
- Review the vesting schedule for the one-time $1,000,000 restricted stock unit grant.
- Check the Company's Definitive Proxy Statement (Schedule 14A filed March 25, 2020) for details on standard executive benefit plans.